{"id":"W2990938107","doi":"10.1080/10428194.2019.1688320","title":"Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Cytarabine; Daunorubicin; Internal medicine; Myeloid leukemia; Population; Leukemia; Surgery; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001270042,0.0002375272,0.0007058969,0.0001524614,0.0001749254,0.0004541442,0.0002217424,0.0003762528,0.001151929],"category_scores_gemma":[0.001897196,0.00009309709,0.001023521,0.0002176,0.0002252677,0.0004700459,0.000396119,0.001012821,0.0001665419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004908033,"about_ca_system_score_gemma":0.000509356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008625124,"about_ca_topic_score_gemma":0.001870641,"domain_scores_codex":[0.9995401,0.0002043151,0.00003975713,0.00008217584,0.00005025829,0.00008334687],"domain_scores_gemma":[0.9989296,0.0002393413,0.0003654667,0.00005809869,0.00004371793,0.0003638486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4104098,0.003411921,0.3775807,0.0007922871,0.003926355,0.0004778394,0.0004832943,0.002077859,0.01015202,0.0004822591,0.002094284,0.1881114],"study_design_scores_gemma":[0.0196692,0.1808123,0.7790788,0.0002821589,0.004324143,0.0008648475,0.0004198906,0.00551961,0.003064861,0.0008314358,0.005089995,0.00004271112],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965422,0.002669699,0.00009724966,0.0001424255,0.0000408909,0.00003316278,0.00007923839,0.000004745642,0.0003903212],"genre_scores_gemma":[0.998777,0.0005735657,0.00007101271,0.0001468073,0.00005927966,0.00001942398,0.0002030905,0.000001298061,0.0001486051],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001270042,"threshold_uncertainty_score":0.006716669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006292642361575587,"score_gpt":0.2358089261766824,"score_spread":0.2295162838151068,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}